Results 51 to 60 of about 286,599 (148)

Fetoscopic laser ablation vs standard management for Type‐II and Type‐III vasa previa

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 3, Page 320-328, March 2026.
ABSTRACT Objective The standard management (SM) for vasa previa (VP) includes antepartum inpatient admission at 28–32 weeks' gestation followed by Cesarean delivery at 34–37 weeks. Case reports and case series have reported on fetoscopic laser ablation (FLA) as an alternative management approach for Types‐II and ‐III VP.
S. Backley, R. H. Chmait, E. P. Bergh, N. Agarwal, A. Llanes, G. Hamadeh, E. Hernandez‐Andrade, A. Johnson, J. Espinoza, A. Salazar, S. Zhu, R. Papanna   +11 more
wiley   +1 more source

Cost–benefit analysis of first‐trimester pre‐eclampsia screening: comparison of multivariable Gaussian algorithm with and without placental growth factor

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 2, Page 162-167, February 2026.
ABSTRACT Objective Pre‐eclampsia (PE) is a leading cause of maternal and neonatal morbidity and mortality worldwide. Early identification of high‐risk pregnancies in the first trimester allows preventive treatment with low‐dose aspirin. This study aimed to evaluate whether multivariable Gaussian algorithm‐based PE screening strategies, with and without
E. Bonacina, M. Armengol‐Alsina, M. Dalmau, A. Casellas, E. Roldán, J. Temprado, E. Del Barco, A. Arias, R. Ferrer‐Costa, N. Maiz, M. Mendoza   +10 more
wiley   +1 more source

Undetected cases after implementation of first‐trimester anomaly scan in low‐risk population: insights from the IMITAS study

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 1, Page 27-33, January 2026.
ABSTRACT Objective To assess the effectiveness of the first‐trimester anomaly scan (FTAS) performed as part of a centrally steered national screening program in The Netherlands by investigating false‐negative cases with a fetal structural anomaly that was not detected at the FTAS.
K. Bronsgeest, E. E. R. Lust, S. C. E. Zaaijer, L. Henneman, N. Crombag, C. M. Bilardo, R.‐J. H. Galjaard, E. Sikkel, A. K. K. Teunissen, M. N. Bekker, M. C. Haak, Collaborators, A. B. C. Coumans, A. Elvan‐Taşpınar, S. Galjaard, A. T. J. I. Go, E. van Leeuwen, G. T. R. Manten, E. Pajkrt   +18 more
wiley   +1 more source

IVF-ET患者HLA-DQB*0301基因rs6928482、rs1056315和-A*3101rs1061235单核苷酸多态性研究

Zhongguo shiyan zhenduanxue, 2020
目的从分子水平探讨HLA-DQB*0301等位基因在体外受精-胚胎移植(IVF-ET)患者不同妊娠结局中的表达差异。方法采用竞争性等位基因特异性PCR(KASP)对330例行IVF-ET手术的不孕症患者HLA-DQB*0301等位基因rs6928482、rs1056315以及HLA-A*3101rs1061235单核苷酸多态性(Single Nucleotide Polymorphisms,SNP)进行了分析,其中妊娠成功组120例,妊娠失败组210例。结果 rs1056315基因型分布不符合Hardy
王惠莹, 刘浏, 柴蓓蓓, 罗加欢, 张若鹏   +4 more
doaj  

子宫畸形的晚期妊娠 29 例临床分析 [PDF]

, 2002
【目的】了解妊娠期子宫畸形的诊治情况及主要并发症。【方法】回顾性分析我院 1980～ 2000 年我院收治的妊娠期合并子宫畸 形的类型、分娩方式、诊断情况及主要并发症。【结果】妊娠晚期合并子宫畸形的剖宫产率明显升高(高达 90%) ,其胎位异常、脐带绕颈、胎膜 早破、产后出血、胎盘粘连、胎儿宫内窘迫的发生率明显增高。【结论】妊娠合并子宫畸形对母婴健康造成很大危害,应尽早作出诊断,减少母 ...
刘玉昆, 谭剑平, 邝健全, 张建平, 陈立斌   +4 more
core  

Adverse neonatal outcomes in small‐for‐gestational age twins identified using twin vs singleton growth charts: systematic review and meta‐analysis

Ultrasound in Obstetrics &Gynecology, Volume 66, Issue 6, Page 706-715, December 2025.
ABSTRACT Objective To evaluate the use of twin vs singleton growth charts for detecting small‐for‐gestational‐age (SGA) twins at risk of adverse neonatal outcomes. Methods MEDLINE, EMBASE, CINAHL, Cochrane and Scopus databases were searched electronically from inception to May 2024.
S. Sorrenti, D. Di Mascio, A. Khalil, F. D'Antonio, F. Zullo, E. D'Alberti, V. D'Ambrosio, I. Mappa, A. Giancotti, G. Rizzo   +9 more
wiley   +1 more source

妊娠梅毒孕期内和妊娠前抗梅毒治疗对分娩结果的影响 [PDF]

, 2006
【目的】探讨妊娠梅毒孕期内和妊娠前抗梅毒治疗对分娩结果的不同影响。【方法】将梅毒孕妇按其发现和治疗时间是在妊娠期内还是妊娠期前分为观察Ⅰ组与观察Ⅱ组，观察Ⅰ组是在妊娠时发现梅毒进行正规的青霉素抗梅毒治疗，观察Ⅱ组是已接受正规青霉素治疗后才怀孕。【结果】观察Ⅰ组165例中。9例Ⅰ期梅毒患者治疗均成功分娩产出活婴，14例Ⅱ期梅毒患者治疗成功11例，142例潜伏梅毒患者治疗成功136例；各期梅毒患者总的治疗成功率94．5％（156／165）。观察Ⅰ组经过足量治疗后所生新生儿中。梅毒血清阳性率为20．6％（34／
苏向阳, 朱慧兰, 谷进, 赖维
core  

单胚胎移植临床结局分析

Zhongshan Daxue xuebao. Yixue kexue ban, 2019
【目的】探讨辅助生殖领域单胚胎移植（SET）的应用前景。【方法】回顾性分析我院生殖中心近两年进行SET的5130例新鲜与冷冻移植周期资料。对新鲜、冷冻周期分别进行比较，并分成选择性和被迫性SET亚组，对比患者的不同胚胎类型、不同年龄段在新鲜与冷冻周期情况下的临床妊娠结局。【结果】在非植入前遗传学检测（PGT）选择性SET周期中，35岁前移植第3天胚胎（D3）和第6天胚胎（D6）的临床妊娠率高达30%，第5天胚胎（D5）的临床妊娠率可高达50%；在PGT周期，小于42岁的患者临床妊娠率可达45 ...
曹苹
doaj  

Performance of non‐invasive prenatal testing in vanishing‐twin and multiple pregnancies: results of TRIDENT‐2 study

Ultrasound in Obstetrics &Gynecology, Volume 66, Issue 6, Page 738-746, December 2025.
ABSTRACT Objective To evaluate the performance of non‐invasive prenatal testing (NIPT) in vanishing‐twin and multiple pregnancies. Methods This study was conducted as part of the TRIDENT‐2 study, in which NIPT was offered as a first‐tier screening test to women with a multiple pregnancy or vanishing‐twin pregnancy between 1 June 2020 and 31 March 2023 ...
J. C. A. van Eekhout, C. J. Bax, L. van Prooyen Schuurman, E. C. Becking, A. J. E. M. van der Ven, D. Van Opstal, E. M. J. Boon, M. V. E. Macville, M. N. Bekker, R. J. H. Galjaard, on behalf of the Dutch NIPT Consortium, E.A. Sistermans, L. Henneman, A. Polstra, E. Voorhoeve, S.L. Zelderen‐Bhola, E.M.J. Boon, M.P.R. Lombardi, M.C. Bakker, E.J. Bradley, E.M.J. Boon, C. Louwerens‐Zintel, M. Smit, M.C. van Maarle, M.B. Tan‐Sindhunata, K. van der Meij, H. Meij, C.J. Bax, E. Pajkrt, I.H. Linskens, L. Martin, J.T. Gitsels‐van der Wal, R. J. H. Galjaard, D. van Opstal, M.I. Srebniak, F.M. Sarquis Jehee, I.H.I.M. Hollink, F. Sleutels, W. de Valk, W.H. Deelen, A.M.S. Joosten, K.E.M. Diderich, M.E. Redeker, A.T.J.I. Go, M.F.C.M. Knapen, S. Galjaard, A.K.E. Prinsen, A.P.G. Braat, M.J.V. Hoffer, N.S. den Hollander, E.J.T. Verweij, M.C. Haak, M.V.E. Macville, S.J.C. Stevens, A. van der Wijngaard, L.H. Houben, M.A.A. van Esch‐Lennarts, L. Hamers, A.G.P. Jetten, S.A.I. Ghesquiere, B. de Koning, M. Zamani Esteki, C.J. Heesterbeek, C.E.M. de Die‐Smulders, H. Brunner, M.J. Pieters, A.B.C. Coumans, D.F.C.M. Smeets, B.H.W. Faas, D. Westra, M.M. Weiss, I. Derks‐Prinsen, I. Feenstra, M. van Rij, E. Sikkel, R.F. Suijkerbuijk, B. Sikkema‐Raddatz, I.M. van Langen, K. Bouman, L.K. Duin, G.H. Schuring‐Blom, K.D. Lichtenbelt, M.N. Bekker, E. van Vliet‐Lachotzki, J. Pot, A. J. E. M. van der Ven, S van 't Padje   +86 more
wiley   +1 more source

VEGF-C蛋白在妊娠期高血压疾病胎盘中的表达及意义

Zhongguo shiyan zhenduanxue, 2011
妊娠期高血压疾病是妊娠期特有的疾病,我国发病率9.4%-10.4%,国外发病率有报道为7%-12%,严重影响母婴健康,是孕产妇和围生儿患病率及死亡率的主要原因[1 ...
隋岩, 王冬梅
doaj